ANI Pharmaceuticals ANIP Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from ANI Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's net debt / EBITDA?
- ANI Pharmaceuticals (ANIP) reported net debt / EBITDA of -0× in Q1 2026.
- How has ANI Pharmaceuticals's net debt / EBITDA changed year-over-year?
- ANI Pharmaceuticals's net debt / EBITDA decreased by 101.1% year-over-year, from 2.5× to -0×.
- What is the long-term trend for ANI Pharmaceuticals's net debt / EBITDA?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's net debt / EBITDA has grown at a -51.2% compound annual growth rate (CAGR), from 6.2× to 0.2×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.